ECRIN has joined the COVID-19 Clinical Research Coalition in order to help building collaborative solutions to the crisis on COVID19 in low-resource settings.
As modern life science research is happening across scientific disciplines, individual scientists and single labs often lack some of the expertise required to address all aspects of a research question.
The project’s purpose is to support the implementation of the declaration of cooperation ‘Towards access to at least 1 million sequenced genomes in the EU by 2022, known as the ‘1+ Million Genomes’ initiative (1+MG).
In the combined efforts to find a cure and a vaccine for COVID-19, time is precious and stakes are high, and research funding must be spent wisely. Until now no university or country has beaten COVID-19, despite the 3,4K COVID-19 clinical studies underway.
May 20th is the International Clinical Trials Day, a special day to remind and to celebrate that
As the world is changing due to the COVID-19 situation, evidence based medicine is more than ever needed and well designed, scientifically and ethically sound clinical trials are necessary to provide this evid
ECRIN is partner in the EULAC PerMed project, and the second newsletter on the project has just been send out. It contains exciting news about the EULAC PerMed project and the activities carried out so far:
The COVID-19 Taskforce has extended and updated the available COVID-19 pages on the ECRIN website. The COVID-19 pages now contains information on:
The PERMIT project has been focusing on a scoping review that will identify the main research methodologies for personalised medicine research. What are the main methodologies used in personalised medicine research? What are the existing needs for standards?
The COVID-19 crisis requires researchers to join forces worldwide to find a cure and a vaccine. Sharing research data is a critical step in this global cooperation effort.
Due to the current situation with the coronavirus, the International Clinical Trials Day 2020 in Berlin have been cancelled.
TRANSVAC2, an European Vaccine Research and Development Infrastructure, supports innovation and accelerates vaccine development by offering high-quality technical services across the R&D pipeline to academic and non-academic research groups, including SMEs.
The world is confronted with the COVID-19 crisis, and all working in healthcare systems taking care of patients have the highest priority. Behind the scenes all forces are joined to support those working to find a cure and a vaccine for COVID-19.
An article related to PedCRIN's work has recently been published in Clinical and Translational Science (CTS) entitled 'Involve Children and Parents in Clinical Studies'.
The ERIC Forum met for its annual meeting from 5-6 February 2020 in Brussels. Representatives from all ERICs (European Research Infrastructure Consortia), including ECRIN, attended.